Ondansetron "stada"

Ondansetron, the active ingredient in Ondansetron "stada", is a 5-HT3 receptor antagonist presented as a 5 mg tablet for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron "stada" as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting across several clinical pathways. - Chemotherapy‑induced nausea and vomiting: Helps reduce the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: Decreases the incidence of nausea during and after radiotherapy. - Post‑operative nausea and vomiting: Lowers the risk of vomiting following surgical procedures.

Adverse reactions to ondansetron are generally mild to moderate, but serious events can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensation. - Abdominal pain: mild discomfort.

Serious or Rare Side Effects: - QT prolongation: abnormal heart rhythm that may lead to arrhythmia. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Serotonin syndrome: agitation, tremor, sweating, rapid heart rate. - Hepatic dysfunction: elevated liver enzymes. - Cardiac arrest: rare but life‑threatening event. - Anaphylaxis: rapid onset of severe allergic response.

When prescribing ondocaine, clinicians should consider several safety aspects. - Cardiac monitoring: patients with known QT prolongation or electrolyte imbalance should be observed. - Electrolyte balance: correct hypokalaemia or hypomagnesemia before use. - Concomitant drugs: review all serotonergic agents for additive effects. - Pregnancy: use only if the potential benefit outweighs risk. - Breastfeeding: assess risk‑benefit ratio before continuation. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Ondansetron may interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Apomatinib (   ).   - Apomatinib   -      

Moderate   t   t   t.

-   g  t.

-  t.

-   g.

-  g.

-  t.

-  -  g.

-  -  - lank  t.

- .